US · guidance
CMS Pub. 100-04, ch. 32, § 130
External Counterpulsation (ECP) Therapy
Commonly referred to as enhanced external counterpulsation, is a non-invasive outpatient treatment for
coronary artery disease refractory medical and/or surgical therapy. Effective for dates of service July 1, 1999,
and after, Medicare will cover ECP when its use is in patients with stable angina (Class III or Class IV,
Canadian Cardiovascular Society Classification or equivalent classification) who, in the opinion of a
cardiologist or cardiothoracic surgeon, are not readily amenable to surgical intervention, such as PTCA or
cardiac bypass, because:
• Their condition is inoperable, or at high risk of operative complications or post-operative failure;
• Their coronary anatomy is not readily amenable to such procedures; or
• They have co-morbid states that create excessive risk.
(Refer to Publication 100-03, section 20.20 for further coverage criteria.)
History
(Rev. 898, Issued: 03-31-06; Effective/Implementation Dates: 03-31-06)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
f1362789f28b8ad67cd98c54fa018d7ab29c30ffac36f8a20786e3743db77f4c
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.